Fujifilm Diosynth Biotechnologies: Press Releases
Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility at Billingham, UK Site
Fujifilm Diosynth Biotechnologies has announced that it has commissioned on time its new mammalian cGMP Cell Banking Facility (CBF) at its Billingham, UK site....
Fujifilm Diosynth Biotechnologies Manufactures a New Licensed Biopharmaceutical
Fujifilm Diosynth Biotechnologies has added another licensed product to its list of commercial biopharmaceutical products, following the announcement that ThromboGenics' has received FDA...
Fujifilm Diosynth Biotechnologies Announces Strategic Alliance With Piramal Healthcare for Production of Antibody Drug Conjugates
Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract development...
Fujifilm Diosynth Biotechnologies Significantly Expands Mammalian Cell Culture CGMP Capabilities
Fujifilm Diosynth Biotechnologies has announced it is expanding its services in mammalian cell line development / process development and adding a new multiproduct cGMP facility at its...
Fujifilm Diosynth Biotechnologies Expands R&D Capabilities at its UK Site
Fujifilm Diosynth Biotechnologies has completed the first phase of a £3m ($4.5m) investment in new equipment and laboratories at its Billingham, UK...
Fujifilm Diosynth Biotechnologies and ContraFect Corporation Collaborate for Novel Anti-Staph Biologic
Fujifilm Diosynth Biotechnologies and ContraFect Corporation have signed a contract to support the process development and cGMP manufacture of CF-301, ContraFect's...
Fujifilm Diosynth Biotechnologies Adds Xcellerex® Single-Use Bioreactor to North Carolina Facility
Fujifilm Diosynth Biotechnologies is to add a 1,000l Xcellerex® single-use bioreactor to its RTP, North Carolina facility, in order to expand its existing contract manufacturing...
MSD BioManufacturing Network Announces New Name: Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies has been announced as the new name for the former Merck BioManufacturing Network (known as MSD BioManufacturing Network outside the US and Canada)...
Fujifilm to Acquire MSD BioManufacturing Network
Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck...
Nuron Biotech Selects the Merck BioManufacturing Network as Manufacturing Supplier for NU100
Nuron Biotech has selected the Merck BioManufacturing Network in the UK to manufacture large-scale GMP clinical supplies of NU100 and undertake process validation leading to long-term...
Twitter
Facebook